BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9785131)

  • 1. DNA content is an independent prognostic indicator in endometrial adenocarcinoma. A Gynecologic Oncology Group study.
    Zaino RJ; Davis AT; Ohlsson-Wilhelm BM; Brunetto VL
    Int J Gynecol Pathol; 1998 Oct; 17(4):312-9. PubMed ID: 9785131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of flow cytometric deoxyribonucleic acid index in endometrial carcinoma: comparison with other clinical-pathologic parameters.
    Susini T; Rapi S; Savino L; Boddi V; Berti P; Massi G
    Am J Obstet Gynecol; 1994 Feb; 170(2):527-34. PubMed ID: 8116708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of DNA ploidy analysis in endometrial adenocarcinoma.
    Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
    Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
    Lanza G; GafĂ  R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
    Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
    Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
    Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic evaluation of endometrial carcinoma by DNA content and histologic factors].
    Shimizu K
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr; 47(4):413-8. PubMed ID: 7730696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA ploidy analysis of endometrial adenocarcinoma using a flow cytometry from paraffin-embedded tissues.
    Takahashi Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Oct; 42(10):1339-44. PubMed ID: 1700035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow-cytometric analysis of nuclear DNA content in endometrial adenocarcinoma. Atypical mitoses are associated with DNA aneuploidy.
    Genest DR; Sheets E; Lage JM
    Am J Clin Pathol; 1994 Sep; 102(3):341-8. PubMed ID: 8085558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial carcinomas--flow cytometric DNA content and S-phase values.
    Jacobsen M; Jakobsen A; Nedergaard L; Andersen JE; Nielsen K
    Pathol Res Pract; 1997; 193(4):283-90. PubMed ID: 9258954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA ploidy status: its impact on early-stage endometrial adenocarcinoma.
    Goodman A; Bell DA; Rice LW
    Gynecol Oncol; 1993 Dec; 51(3):355-61. PubMed ID: 8112645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA content as a prognostic factor in endometrial carcinoma.
    Newbury R; Schuerch C; Goodspeed N; Fanning J; Glidewell O; Evans M
    Obstet Gynecol; 1990 Aug; 76(2):251-7. PubMed ID: 2371030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic correlation of DNA flow cytometric content analysis (DFCA), surgical staging, and estrogen/progesterone receptor status in endometrial adenocarcinoma.
    Konski AA; Domenico D; Irving D; Tyrkus M; Neisler J; Phibbs G; Mah J; Eggleston W
    Am J Clin Oncol; 1996 Apr; 19(2):164-8. PubMed ID: 8610642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric analysis of the DNA content of adenocarcinoma of the lung, especially for patients with stage 1 disease with long term follow-up.
    Tanaka I; Masuda R; Furuhata Y; Inoue M; Fujiwara M; Takemura T
    Cancer; 1995 May; 75(10):2461-5. PubMed ID: 7736389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric cancer cell DNA content correlates with early and late results after gastrectomy.
    Carlini M; Garofalo A; Rinaldi G; D'Agnano I; D'Angelo C; Zupi G; Vecchione A; Santoro E
    Int Surg; 1994; 79(2):114-9. PubMed ID: 7928145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study on DNA content and cell cycle phase analysis in endometrial carcinoma].
    Xue F; Jiao S; Zhao F
    Zhonghua Fu Chan Ke Za Zhi; 1996 Apr; 31(4):216-9. PubMed ID: 8758776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of cell kinetics in endometrial adenocarcinoma.
    Mariani L; Conti L; Antenucci A; Vercillo M; Atlante M; Gandolfo GM
    Anticancer Res; 2000; 20(5B):3569-74. PubMed ID: 11131664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of DNA ploidy in endometrial cancer.
    Ikeda M; Watanabe Y; Nanjoh T; Noda K
    Gynecol Oncol; 1993 Jul; 50(1):25-9. PubMed ID: 8349160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of DNA ploidy in adenocarcinoma of the pancreas. A flow cytometric study of paraffin-embedded specimens.
    Porschen R; Remy U; Bevers G; Schauseil S; Hengels KJ; Borchard F
    Cancer; 1993 Jun; 71(12):3846-50. PubMed ID: 8508352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative prognostic significance of DNA flow cytometry and histologic grading in endometrial carcinoma.
    Quillamor RM; Furlong JW; Hoschner JA; Wynn RM
    Gynecol Obstet Invest; 1988; 26(4):332-7. PubMed ID: 3229666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy.
    Pollack A; Zagars GK; el-Naggar AK; Gauwitz MD; Terry NH
    Cancer; 1994 Apr; 73(7):1895-903. PubMed ID: 7511039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.